Healthcare -
Biotechnology - NASDAQ - US
$ 4.46
-1.9 %
$ 249 M
Market Cap
-3.19
P/E
FHTX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities FHTX - Foghorn Therapeutics Inc.
105 M
LAST VALUE
673.31%
2 YEAR CAGR
34.48%
5 YEAR CAGR
0.00%
10 YEAR CAGR